 COST EFFECTIVE NON INVASIVE DIAGNOSTIC MODALITIES AND PREDICTIVE MODEL FOR DEVELOPMENT AND PROGRESSION OF FIBROSIS AMONG PATIENTS WITH HEPATITIS B, HEPATITIS C INFECTION OR NON ALCOHOLIC FATTY LIVER DISEASE: 